Journal of Inflammatory Diseases
The Official Journal of Qazvin University of Medical Sciences
Quantitative Structure-Activity Relationships and Molecular Docking Simulation of Allicin Compounds as Inhibitors of COVID-19 Protease Enzyme
Authors
Abstract
Background: Coronavirus (CoV) is a group of viruses that cause disease in humans and animals. These viruses contain crown-shaped spike glycoproteins on their surface. Objective: We conducted a quantitative structure-activity relationship (QSAR) study on a series of 36 compounds of allicin to assess their antiviral activities against the main protease of COVID-19. Methods: In the present descriptive-analytic study, the information on the structure of compounds, the COVID-19 protease enzyme, and the Allicin derivatives was obtained from the databases such as the Research Collaboratory for Structural Bioinformatics’ Protein Data Bank (PDB) and PubChem. The QSAR method, analysis of correlations and multiple linear regressions were carried out. Six molecular descriptors such as constitutional and molecular topology descriptors were selected for the model. Finally, molecular docking was performed in iGEMDOCK 2.1 software. Results: The obtained multi-parametric model reported a correlation coefficient of about 0.89, indicating that the model was able to satisfactory predict the antiviral activity of allicin compounds. Conclusion: The findings obtained can be valuable in designing, synthesizing, and developing novel antiviral agents with allicin-based scaffold.
Highlights
Copyright
© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Natural Marine-derived Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease: A Comprehensive Computational Study
Nowroozi G, Rahmani S, Jalali P, Zareie A, Asvar Z, et al. Natural Marine-derived Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease: A Comprehensive Computational Study. J Rep Pharm Sci. 2025;13(1):e159451. doi: https://doi.org/10.5812/jrps-159451
A Computational Study of Some Benzenesulfonamide Derivatives as HIV- 1 Protease Enzyme Inhibitors: Three-Dimensional Quantitative Structure-Activity Relationship and Molecular Docking
Abdizade R, Abdizadeh T. A Computational Study of Some Benzenesulfonamide Derivatives as HIV- 1 Protease Enzyme Inhibitors: Three-Dimensional Quantitative Structure-Activity Relationship and Molecular Docking. Koomesh. 2025;27(6):e159682. doi: https://doi.org/10.69107/koomesh-159682
The Kinetics of 3-Chymotrypsin-Like Cysteine Protease (3CLpro) Inhibition by Otostegia persica and Otostegia aucheri Extracts and Fractions: An In Vitro Model for Coronavirus Enzyme Inhibition
Moein S, Zebarjad Z, Moein M, Sabahi Z. The Kinetics of 3-Chymotrypsin-Like Cysteine Protease (3CLpro) Inhibition by Otostegia persica and Otostegia aucheri Extracts and Fractions: An In Vitro Model for Coronavirus Enzyme Inhibition. Jundishapur J Nat Pharm Prod. 2025;20(3):e162409. doi: https://doi.org/10.5812/jjnpp-162409
The Alkaloids of Isatis indigotica as Promising Candidates against COVID-19: A Molecular Docking Simulation for Drug Development
Kazemi F, Mojarrab M, Bahrami G, Miraghaee S, Hadidi S, et al. The Alkaloids of Isatis indigotica as Promising Candidates against COVID-19: A Molecular Docking Simulation for Drug Development. J Rep Pharm Sci. 2022;11(2):e146235. doi: https://doi.org/10.4103/jrptps.JRPTPS_113_21
In Silico Study of Pacific oyster Antiviral Polypeptides as Potential Inhibitory Compounds for SARS-CoV-2 Main Protease
Mohammadi M, Rajabi S, Piroozmand A, Mirhosseini SA. In Silico Study of Pacific oyster Antiviral Polypeptides as Potential Inhibitory Compounds for SARS-CoV-2 Main Protease. Jentashapir J Cell Mol Biol. 2020;11(3):e108932. doi: https://doi.org/10.5812/jjcmb.108932
- Scopus by DOI: 0
Last Update: 2 days ago
- Scopus by Title: 0
Last Update: 2 days ago
- Scopus by Title (Ref): 0
Last Update: 2 days ago
- CrossRef: 0
Last Update: 5 days ago
- OpenAlex: 0
Last Update: 1 hour ago
- OpenCitations: 0
Last Update: 3 days ago